# \[e-med\] (3)ArteSunate AmodiaQuine Winthrop® a une durée de validité étendue à 36 mois

**URL:** <https://talk.edrugplus.org/t/e-med-3-artesunate-amodiaquine-winthrop-a-une-duree-de-validite-etendue-a-36-mois/34518>\
**Category:** e-med\
**Created:** [October 22, 2010, 11:32am UTC](https://talk.edrugplus.org/t/e-med-3-artesunate-amodiaquine-winthrop-a-une-duree-de-validite-etendue-a-36-mois/34518 "2010-10-22T11:32:19Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![c.bruneton](https://avatars.discourse-cdn.com/v4/letter/c/3ec8ea/32.png) [@c.bruneton](https://talk.edrugplus.org/u/c.bruneton)\
**Post date:** [October 22, 2010, 11:32am UTC](https://talk.edrugplus.org/t/e-med-3-artesunate-amodiaquine-winthrop-a-une-duree-de-validite-etendue-a-36-mois/34518/1 "2010-10-22T11:32:19Z")

</div>

Cher Loïc

Merci de bien vouloir consulter la liste des médicaments proposés au 18ème  
Comité d' Expert pour la Sélection et l'utilisation des médicaments  
Essentiels.  
[http://www.who.int/selection\_medicines/committees/expert/18/applications/artesunate/en/index.html](http://www.who.int/selection_medicines/committees/expert/18/applications/artesunate/en/index.html)

Tu y trouveras la proposition d'inclusion ci-dessous

Artesunate + amodiaquine fixed-dose combination (Inclusion) -- Adults and  
Children  
Drug information  
Drug name: Artesunate + amodiaquine fixed-dose combination  
Section 6.5.3: Antimalarial medicines  
Formulation:

Application prepared by:  
Sanofi-Aventis  
:: Covering letter from Sanofi-Aventis [pdf 423kb]  
:: Application for inclusion of artesunate + amodiaquine [pdf 475kb]  
:: Letter from Dr L. Savioli, Acting Director, Global Malaria Programme [pdf  
61kb]  
:: Letter of support from DNDi [pdf 51kb]

Bonne journée à tous

Carinne Bruneton  
ReMeD